ABSTRACT SUBMISSION HAS BEEN SUSPENDED UNTIL FURTHER NOTICE DUE TO POSTPONEMENT OF THE EVENT. MORE INFORMATION ABOUT ISOP 2021 TO BE PUBLISHED SOON.
The Scientific Committee of the 20th ISoP Annual Meeting invites abstracts to be submitted for either oral or poster presentation related to the subjects of pharmacovigilance and drug safety.
Abstracts will be reviewed by the ISoP 2020 Scientific Committee, and each decision will be notified to submitters by 25 June 2020. Notification of abstract acceptance or rejection will be communicated to the lead author’s e-mail address (submitter of the abstract).
Please note that if an abstract is accepted for presentation (oral or as poster), at least one of the authors (presenting author) must register for ISoP 2020. Registration should be made immediately after notification of abstract acceptance, and at least before 15 July 2020. Presenting authors must attend the conference in order to present the abstract.
The Scientific Committee’s decisions will be based upon evaluation of the abstract’s scientific standard. The Scientific Committee will allocate each accepted abstract to the most appropriate form of presentation (oral or poster). After selection, to all presenting authors will be sent full information regarding PowerPoint preparation, poster size, style and layout, as appropriate.
Accepted abstracts, which have been received by the submission deadline, will be published in ISoP’s official journal, Drug Safety.
All accepted posters for the ISoP 2020 Annual Meeting are eligible for poster prizes which will be awarded to the three best posters.
If you have any questions regarding preparing, submitting, amending or withdrawing an abstract, please contact:
Phone: +420 261 174 312